Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-041703
Filing Date
2021-08-05
Accepted
2021-08-05 17:04:49
Documents
64
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aveo-10q_20210630.htm   iXBRL 10-Q 3300273
2 EX-31.1 aveo-ex311_7.htm EX-31.1 16532
3 EX-31.2 aveo-ex312_11.htm EX-31.2 16529
4 EX-32.1 aveo-ex321_10.htm EX-32.1 4471
5 EX-32.2 aveo-ex322_8.htm EX-32.2 4460
  Complete submission text file 0001564590-21-041703.txt   12323922

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA aveo-20210630.xsd EX-101.SCH 67883
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aveo-20210630_cal.xml EX-101.CAL 52654
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aveo-20210630_def.xml EX-101.DEF 263250
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aveo-20210630_lab.xml EX-101.LAB 527387
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aveo-20210630_pre.xml EX-101.PRE 410073
11 EXTRACTED XBRL INSTANCE DOCUMENT aveo-10q_20210630_htm.xml XML 2764034
Mailing Address 30 WINTER STREET BOSTON MA 02108
Business Address 30 WINTER STREET BOSTON MA 02108 857-400-0101
AVEO PHARMACEUTICALS, INC. (Filer) CIK: 0001325879 (see all company filings)

EIN.: 043581650 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34655 | Film No.: 211149332
SIC: 2834 Pharmaceutical Preparations